Nalaganje...
Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood malignancy that arises from the clonal expansion of transformed T-cell precursors. Although T-ALL prognosis has significantly improved due to the development of intensive chemotherapeutic protocols, primary drug-resistant and relapse...
Shranjeno v:
| izdano v: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6073309/ https://ncbi.nlm.nih.gov/pubmed/29949919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19071878 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|